Navigation Links
CHEST 2008: Featured abstracts
Date:10/28/2008

tion time measurements, at the beginning of their shift, and at the end of the same 12-hour shift. Among day-shift nurses, the reaction times were unchanged across the shift; however, night-shift nurses performed better on reaction tests towards the end of the shift. Researchers speculate that circadian influences may play a role in nurse reaction time.

#7214
ESSENTIAL AMINO ACIDS MAY IMPROVE STRENGTH IN COPD PATIENTS
(Wednesday, October 29, 1:00 PM EST)

Patients with chronic obstructive pulmonary disease (COPD) may improve muscle strength and exercise endurance by taking essential amino acid supplements. For 3 months, researchers from Italy treated 20 patients with stage 3 and 4 COPD with 8 g of essential amino acids plus usual pharmacologic treatment. Compared with 20 patients in the matched control group, after 3 months, patients in the study group showed a statistically significant increase of muscle strength and covered distance during a 6-minute walk test, and a decrease of breathless degree. Researchers conclude that essential amino acids supplementation may be a valid adjunct therapy for patients with advanced COPD, especially for those presenting with loss of muscle mass or respiratory muscle weakness.

#6601
NASAL SPRAY IMPROVES RHINITIS-RELATED CHRONIC COUGH
(Wednesday, October 29, 1:00 PM EST)

Patients with rhinitis-related chronic cough may be able to control their cough using nasal sprays. Researchers at Cough Center, Inc, in California treated 266 patients (ages 7 to 85 years) with seasonal allergic (3 percent), nonallergic (65 percent), or mixed rhinitis (32 percent) with open-label combinations of azelastine nasal spray, steroid nasal sprays, ipratropium nasal spray, or cromolyn nasal spray. The median duration of cough was 7 years and the percentage of smokers was less than 1 percent. Of the patients, 72 percent with rhinitis-associated chronic cough experienced improvement with intranasal therapy. The
'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18

Related medicine news :

1. News briefs from the journal Chest, August 2007
2. Fat on chest and upper back increases risk of insulin resistance
3. U.S. Reps. Oberstar and Walz Discuss DM&E Railroad Expansion With Rochester, Minn. Leaders
4. Manchester researchers announce new methods of beating breast cancer
5. Eckert Seamans Announces Major Expansion in Philadelphia, West Chester and Harrisburg
6. Chest Compressions Key to Revised CPR Guidelines
7. Dong-A PharmTech Signs Licensing Deal With Otechestvennye to Market Zydena in Russia
8. Reflux Can Precipitate Chest Pain, Cough
9. Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Childrens Dimetapp Cold & Chest Congestion
10. News briefs from the November issue of Chest
11. Natures Baby Organics Announces Ah-Choo! Chest Rub
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3Hand Surgeons Take Ethics into Their Own Hands 2Hand Surgeons Take Ethics into Their Own Hands 3Hand Surgeons Take Ethics into Their Own Hands 4Negative Pressure Wound Devices Draw FDA Notice, Advice 2California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 1California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 2California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 3California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 4California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 5California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 6California Doctors to Get Wired in States Largest e Prescribing Initiative 49184 7A M Best Upgrades ProAssurance Group to A 28Excellent 29 49182 1A M Best Upgrades ProAssurance Group to A 28Excellent 29 49182 2Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 1Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 2Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 3Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 4Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 5Unique Collaboration Between TB Alliance and Tibotec To Accelerate Tuberculosis Drug Development 49180 6